Glyburide and fetal safety; transplacental pharmacokinetic considerationsKOREN, Gideon.Reproductive toxicology (Elmsford, NY). 2001, Vol 15, Num 3, pp 227-229, issn 0890-6238Article

Trends of medication errors in hospitalized childrenKOREN, Gideon.Journal of clinical pharmacology. 2002, Vol 42, Num 7, pp 707-710, issn 0091-2700Article

Ethical framework for observational studies of medicinal drug exposure in pregnancyKOREN, Gideon.Teratology (Philadelphia, PA). 2002, Vol 65, Num 4, pp 191-195, issn 0040-3709Article

P-glycoprotein in the Developing Human Brain: A Review of the Effects of Ontogeny on the Safety of Opioids in NeonatesLAM, Jessica; KOREN, Gideon.Therapeutic drug monitoring. 2014, Vol 36, Num 6, pp 699-705, issn 0163-4356, 7 p.Article

Cyclosporine and Lactation: When the Mother Is Willing to BreastfeedOSADCHY, Alla; KOREN, Gideon.Therapeutic drug monitoring. 2011, Vol 33, Num 2, pp 147-148, issn 0163-4356, 2 p.Article

Quantity as an Expression of Quality : Relationship Between Serum Drug Concentrations and Quality of LifeRIEDER, Michael; KOREN, Gideon.Therapeutic drug monitoring. 2008, Vol 30, Num 5, pp 557-558, issn 0163-4356, 2 p.Article

Therapeutic drug monitoring of antithyroid drugs in pregnancy : The knowledge gapsKOREN, Gideon; SOLDIN, Offie.Therapeutic drug monitoring. 2006, Vol 28, Num 1, pp 12-13, issn 0163-4356, 2 p.Article

The role of VariZIG in pregnancyBAPAT, Priya; KOREN, Gideon.Expert review of vaccines. 2013, Vol 12, Num 11, pp 1243-1248, issn 1476-0584, 6 p.Article

Unsuspected Prenatal Opioid Exposure: Long-Term Detection by Alternative MatricesMOLLER, Monique; KOREN, Gideon.Therapeutic drug monitoring. 2010, Vol 32, Num 1, pp 1-2, issn 0163-4356, 2 p.Article

Clinical relevance of therapeutic drug monitoring during pregnancyLOEBSTEIN, Ronen; KOREN, Gideon.Therapeutic drug monitoring. 2002, Vol 24, Num 1, pp 15-22, issn 0163-4356Conference Paper

Preschoolers' Hair Cortisol Levels Are Linked to Parental IncomeHENLEY, Phaedra; KOREN, Gideon.Therapeutic drug monitoring. 2014, Vol 36, Num 2, pp 133-135, issn 0163-4356, 3 p.Article

Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humansCOHEN-KEREM, Raanan; KOREN, Gideon.Neurotoxicology and teratology. 2003, Vol 25, Num 1, pp 1-9, issn 0892-0362, 9 p.Article

Bias in maternal reports of smoking during pregnancy associated with fetal distressWONG, Matthew; KOREN, Gideon.Canadian journal of public health. 2001, Vol 92, Num 2, pp 109-112, issn 0008-4263Article

Antidepressant use during pregnancy: the benefit-risk ratioKOREN, Gideon; NORDENG, Hedvig.American journal of obstetrics and gynecology. 2012, Vol 207, Num 3, pp 157-163, issn 0002-9378, 7 p.Article

Universal or Targeted Screening for Fetal Alcohol Exposure : A Cost-Effectiveness AnalysisZELNER, Irene; KOREN, Gideon.Therapeutic drug monitoring. 2009, Vol 31, Num 2, pp 170-172, issn 0163-4356, 3 p.Article

Pregnancy outcome after exposure to injectable ribavirin during embryogenesisREZVANI, Massoud; KOREN, Gideon.Reproductive toxicology (Elmsford, NY). 2006, Vol 21, Num 1, pp 113-115, issn 0890-6238, 3 p.Article

Management of paracetamol overdose. Current controversiesKOZER, Eran; KOREN, Gideon.Drug safety. 2001, Vol 24, Num 7, pp 503-512, issn 0114-5916Article

New frontiers in pediatric drug therapyBAILEY, Benoit; KOREN, Gideon.The Pediatric clinics of North America. 1997, Vol 44, Num 1, issn 0031-3955, 279 p.Serial Issue

Emerging Biomarkers of Intrauterine Neonatal and Pediatric Exposures to XenobioticsDELANO, Kaitlyn; KOREN, Gideon.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x, 1059-1070 [11 p.]Article

Hair Methylmercury: A New Indication for Therapeutic MonitoringSCHOEMAN, Katherine; BEND, John R; KOREN, Gideon et al.Therapeutic drug monitoring. 2010, Vol 32, Num 3, pp 289-293, issn 0163-4356, 5 p.Conference Paper

The fatty acid ethyl esters (FAEE) hair test: emerging technology for the diagnosis of fetal alcohol spectrum disorders (FASD)KULAGA, Vivian; PRAGST, Fritz; KOREN, Gideon et al.Annales de toxicologie analytique. 2009, Vol 21, Num 2, pp 61-65, issn 0768-598X, 5 p.Article

A tubule cell model for ifosfamide nephrotoxicityALEKSA, Katarina; HALACHMI, Naomi; ITO, Shinya et al.Canadian journal of physiology and pharmacology. 2005, Vol 83, Num 6, pp 499-508, issn 0008-4212, 10 p.Article

Effectiveness of bupropion for smoking cessation during pregnancyCHAN, Brian; EINARSON, Adrienne; KOREN, Gideon et al.Journal of addictive diseases. 2005, Vol 24, Num 2, pp 19-23, issn 1055-0887, 5 p.Article

Recall bias of the symptoms of nausea and vomiting of pregnancyKOREN, Gideon; MALTEPE, Caroline; NAVIOZ, Yvette et al.American journal of obstetrics and gynecology. 2004, Vol 190, Num 2, pp 485-488, issn 0002-9378, 4 p.Article

Herbal medicine use in pregnancy : A new frontier in clinical teratologyGALLO, Michael; EINARSON, Adrienne; KOREN, Gideon et al.Birth defects research. Part B. Developmental and reproductive toxicology. 2003, Vol 68, Num 6, pp 499-500, issn 1542-9733, 2 p.Article